Orange Book product · Generic (ANDA)
DROPERIDOL
DROPERIDOL
At a glance
Dec 14, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 14, 2017
8 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
DROPERIDOL
Strength
2.5MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 208197
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DROPERIDOL
- —INAPSINEBrand (NDA)
NDA 016796 · RISING
- 1995DROPERIDOLGeneric (ANDA)
ANDA 072272 · HOSPIRA
- 1991DROPERIDOLGeneric (ANDA)
ANDA 073520 · WATSON LABS
- 1991DROPERIDOLGeneric (ANDA)
ANDA 073521 · WATSON LABS
- 1991DROPERIDOLGeneric (ANDA)
ANDA 073523 · WATSON LABS
- 1988DROPERIDOLGeneric (ANDA)
ANDA 072123 · AM REGENT
- 1988DROPERIDOLGeneric (ANDA)
ANDA 072335 · LUITPOLD
- 1988DROPERIDOLGeneric (ANDA)
ANDA 072018 · ASTRAZENECA
- 1988DROPERIDOLGeneric (ANDA)
ANDA 072019 · IGI LABS INC
- 1988DROPERIDOLGeneric (ANDA)
ANDA 072020 · IGI LABS INC
- 1988DROPERIDOLGeneric (ANDA)
ANDA 072021 · IGI LABS INC
- 1988DROPERIDOLGeneric (ANDA)
ANDA 071750 · SMITH AND NEPHEW
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
